1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Anoxemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, SJ; Kim, HC; Kim, HS; Kim, SH; Lee, HJ; Lim, S; Lü, J; Park, KY | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Anoxemia
Article | Year |
---|---|
1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
Topics: 1-Phosphatidylinositol 4-Kinase; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Capillaries; Cell Line, Tumor; Endothelial Cells; Endothelium, Vascular; Humans; Hydrolyzable Tannins; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Phosphorylation; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Umbilical Veins; Vascular Endothelial Growth Factor A | 2010 |